The role of adiponectin in human vascular physiology

International Journal of Cardiology

Volumn 155, Issue 2, 2012, Pages 188-193

  Vaiopoulos, Aristeidis G ^a   Marinou, Kyriakoula ^a   Christodoulides, Constantinos ^b   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adiponectin; Cardiovascular; Physiology

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RIMONABANT;

ADJUVANT THERAPY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL MIGRATION; CELL PROLIFERATION; DRUG TARGETING; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; GLUCOSE METABOLISM; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART PROTECTION; HUMAN; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; LIPID METABOLISM; METABOLIC SYNDROME X; MOLECULAR PATHOLOGY; NEOINTIMA; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ADIPONECTIN; ADIPOSE TISSUE; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; HUMANS;

EID: 84857061051     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.07.047     Document Type: Review

References (68)

1. F. Lago, R. Gomez, J.J. Gomez-Reino, C. Dieguez, and O. Gualillo Adipokines as novel modulators of lipid metabolism Trends Biochem Sci 34 2009 500 510
2. S. Galic, J.S. Oakhill, and G.R. Steinberg Adipose tissue as an endocrine organ Mol Cell Endocrinol 316 Mar. 25 2010 129 139
3. G.R. Hajer, T.W. van Haeften, and F.L. Visseren Adipose tissue dysfunction in obesity, diabetes, and vascular diseases Eur Heart J 29 2008 2959 2971
4. E. Maury, and S.M. Brichard Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome Mol Cell Endocrinol 314 2010 1 16
5. F. Ziemke, and C.S. Mantzoros Adiponectin in insulin resistance: lessons from translational research Am J Clin Nutr 91 2010 258S 261S
6. W. Kiess, S. Petzold, and M. Topfer Adipocytes and adipose tissue Best Pract Res Clin Endocrinol Metab 22 2008 135 153
7. M. Guerre-Millo Adiponectin: an update Diabetes Metab 34 2008 12 18
8. R. Tarquini, C. Lazzeri, G. Laffi, and G.F. Gensini Adiponectin and the cardiovascular system: from risk to disease Intern Emerg Med 2 2007 165 176
9. M. Liu, and F. Liu Transcriptional and post-translational regulation of adiponectin Biochem J 425 2009 41 52
10. K. Marinou, D. Tousoulis, A.S. Antonopoulos, E. Stefanadi, and C. Stefanadis Obesity and cardiovascular disease: from pathophysiology to risk stratification Int J Cardiol 138 2010 3 8
11. G. Iacobellis, and G. Barbaro The double role of epicardial adipose tissue as pro- and anti-inflammatory organ Horm Metab Res 40 2008 442 445
12. S.S. Deepa, and L.Q. Dong APPL1: role in adiponectin signaling and beyond Am J Physiol Endocrinol Metab 296 2009 E22 E36
13. K.J. Clarke, Q. Zhong, D.D. Schwartz, E.S. Coleman, R.J. Kemppainen, and R.L. Judd Regulation of adiponectin secretion by endothelin-1 Biochem Biophys Res Commun 312 2003 945 949
14. T. Kadowaki, and T. Yamauchi Adiponectin and adiponectin receptors Endocr Rev 26 2005 439 451
15. B.J. Goldstein, R.G. Scalia, and X.L. Ma Protective vascular and myocardial effects of adiponectin Nat Clin Pract Cardiovasc Med 6 2009 27 35
16. W. Zhu, K.K. Cheng, P.M. Vanhoutte, K.S. Lam, and A. Xu Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention Clin Sci (Lond) 114 2008 361 374
17. J.R. Sowers Endocrine functions of adipose tissue: focus on adiponectin Clin Cornerstone 9 2008 32 38 discussion 39-40
18. T.A. Hopkins, N. Ouchi, R. Shibata, and K. Walsh Adiponectin actions in the cardiovascular system Cardiovasc Res 74 2007 11 18
19. A. Stofkova Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity Endocr Regul 43 2009 157 168
20. A.H. Sprague, and R.A. Khalil Inflammatory cytokines in vascular dysfunction and vascular disease Biochem Pharmacol 78 2009 539 552
21. B.J. Goldstein, and R. Scalia Adiponectin: a novel adipokine linking adipocytes and vascular function J Clin Endocrinol Metab 89 2004 2563 2568
22. W. Xi, H. Satoh, H. Kase, K. Suzuki, and Y. Hattori Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin Biochem Biophys Res Commun 332 2005 200 205
23. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M.J. Quon Adiponectin stimulates production of nitric oxide in vascular endothelial cells J Biol Chem 278 2003 45021 45026
24. N. Ouchi, H. Kobayashi, and S. Kihara Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells J Biol Chem 279 2004 1304 1309
25. K. Mahadev, X. Wu, S. Donnelly, R. Ouedraogo, A.D. Eckhart, and B.J. Goldstein Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells Cardiovasc Res 78 2008 376 384
26. C. Kobashi, M. Urakaze, and M. Kishida Adiponectin inhibits endothelial synthesis of interleukin-8 Circ Res 97 2005 1245 1252
27. X. Wu, K. Mahadev, L. Fuchsel, R. Ouedraogo, S.Q. Xu, and B.J. Goldstein Adiponectin suppresses IkappaB kinase activation induced by tumor necrosis factor-alpha or high glucose in endothelial cells: role of cAMP and AMP kinase signaling Am J Physiol Endocrinol Metab 293 2007 E1836 E1844
28. N. Ouchi, S. Kihara, and Y. Arita Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway Circulation 102 2000 1296 1301
29. S.Q. Xu, K. Mahadev, and X. Wu Adiponectin protects against angiotensin II or tumor necrosis factor alpha-induced endothelial cell monolayer hyperpermeability: role of cAMP/PKA signaling Arterioscler Thromb Vasc Biol 28 2008 899 905
30. J.P. Whitehead, A.A. Richards, I.J. Hickman, G.A. Macdonald, and J.B. Prins Adiponectin-a key adipokine in the metabolic syndrome Diabetes Obes Metab 8 2006 264 280
31. B. Chandrasekar, W.H. Boylston, K. Venkatachalam, N.J. Webster, S.D. Prabhu, and A.J. Valente Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression J Biol Chem 283 2008 24889 24898
32. A. Matsuda, Y. Suzuki, K. Kondo, Y. Ikeda, and K. Umemura Hypercholesterolemia induces regression in neointimal thickening due to apoptosis of vascular smooth muscle cells in the hamster endothelial injury model Cardiovasc Res 53 2002 512 523
33. Y. Motobayashi, Y. Izawa-Ishizawa, and K. Ishizawa Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells Hypertens Res 32 2009 188 193
34. M. Takaoka, D. Nagata, and S. Kihara Periadventitial adipose tissue plays a critical role in vascular remodeling Circ Res 105 2009 906 911
35. S.H. Han, M.J. Quon, J.A. Kim, and K.K. Koh Adiponectin and cardiovascular disease: response to therapeutic interventions J Am Coll Cardiol 49 2007 531 538
36. P. Eren, S. Camus, and G. Matrone Adiponectinemia controls pro-angiogenic cell therapy Stem Cells 27 2009 2712 2721
37. V. Lavoie, A.E. Kernaleguen, G. Charron, N. Farhat, M. Cossette, A.M. Mamarbachi, B.G. Allen, E. Rheaume, and J.C. Tardif Functional effects of adiponectin on endothelial progenitor cells Obesity (Silver Spring) 19 2011 722 728
38. J. Chang, Y. Li, Y. Huang, K.S. Lam, R.L. Hoo, W.T. Wong, K.K. Cheng, Y. Wang, P.M. Vanhoutte, and A. Xu Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway Diabetes 59 2010 2949 2959
39. R.H. Amin, S.T. Mathews, A. Alli, and T. Leff Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPAR{gamma}-dependent autocrine mechanism Am J Physiol Heart Circ Physiol 299 2010 H690 98
40. R. Shibata, K. Sato, and M. Kumada Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment Cardiovasc Res 74 2007 471 479
41. L. Tao, E. Gao, and X. Jiao Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress Circulation 115 2007 1408 1416
42. R. Shibata, K. Sato, and D.R. Pimentel Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat Med 11 2005 1096 1103
43. F. Otsuka, S. Sugiyama, and S. Kojima Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease J Am Coll Cardiol 48 2006 1155 1162
44. D. Fujioka, K. Kawabata, and Y. Saito Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart Am J Physiol Heart Circ Physiol 290 2006 H2409 H2416
45. R.R. Russell III, J. Li, and D.L. Coven AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury J Clin Invest 114 2004 495 503
46. C. Antoniades, A.S. Antonopoulos, D. Tousoulis, and C. Stefanadis Adiponectin: from obesity to cardiovascular disease Obes Rev 10 2009 269 279
47. M. Maynadier, I. Basile, and M. Gary-Bobo Adiponectin normalization: a clue to the anti-metabolic syndrome action of rimonabant Drug Discov Today 14 2009 192 197
48. B.I. Shand, R.S. Scott, P.A. Elder, and P.M. George Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance Diabetes Obes Metab 5 2003 349 353
49. H.F. Gu Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms Biomark Insights 4 2009 123 133
50. C. Menzaghi, V. Trischitta, and A. Doria Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease Diabetes 56 2007 1198 1209
51. D.A. Ferrarezi, N. Cheurfa, A.F. Reis, F. Fumeron, and G. Velho Adiponectin gene and cardiovascular risk in type 2 diabetic patients: a review of evidences Arq Bras Endocrinol Metabol 51 2007 153 159
52. K. Sugamura, S. Sugiyama, and Y. Fujiwara Cannabinoid 1 receptor blockade reduces atherosclerosis with enhances reverse cholesterol transport J Atheroscler Thromb 17 2010 141 147
53. K. Kondo, R. Shibata, and K. Unno Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model Circ Cardiovasc Interv 3 2010 166 173
54. S. Li, H.J. Shin, E.L. Ding, and R.M. van Dam Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis JAMA 302 2009 179 188
55. C. Lara-Castro, N. Luo, P. Wallace, R.L. Klein, and W.T. Garvey Adiponectin multimeric complexes and the metabolic syndrome trait cluster Diabetes 55 2006 249 259
56. C. Heidemann, Q. Sun, and R.M. van Dam Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women Ann Intern Med 149 2008 307 316
57. G.K. Shetty, P.A. Economides, E.S. Horton, C.S. Mantzoros, and A. Veves Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes Diabetes Care 27 2004 2450 2457
58. M. Matsubara, S. Maruoka, and S. Katayose Decreased plasma adiponectin concentrations in women with dyslipidemia J Clin Endocrinol Metab 87 2002 2764 2769
59. Q. Zhuo, Z.Q. Wang, and P. Fu Association between adiponectin and metabolic syndrome in older adults from major cities of China Biomed Environ Sci 23 2010 53 61
60. K. Hara, M. Horikoshi, and T. Yamauchi Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome Diabetes Care 29 2006 1357 1362
61. M. Torigoe, H. Matsui, and Y. Ogawa Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men Clin Endocrinol (Oxf) 67 2007 276 281
62. K.C. Tan, A. Xu, and W.S. Chow Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation J Clin Endocrinol Metab 89 2004 765 769
63. W.S. Chow, B.M. Cheung, and A.W. Tso Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study Hypertension 49 2007 1455 1461
64. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737
65. J. Persson, K. Lindberg, T.P. Gustafsson, P. Eriksson, G. Paulsson-Berne, and P. Lundman Low plasma adiponectin concentration is associated with myocardial infarction in young individuals J Intern Med 268 2010 194 205
66. Y. Matsuo, T. Imanishi, and A. Kuroi Effects of plasma adiponectin levels on the number and function of endothelial progenitor cells in patients with coronary artery disease Circ J 71 2007 1376 1382
67. P.J. Avery, S.K. Patel, I.M. Ibrahim, M. Walker, and B.D. Keavney Common variation in the adiponectin gene has an effect on systolic blood pressure J Hum Hypertens 2011 [Electronic publication ahead of print]
68. G. Hoefle, A. Muendlein, and C.H. Saely The - 11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men Thromb Haemost 97 2007 451 457